SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-001415
Filing Date
2024-01-17
Accepted
2024-01-17 08:40:29
Documents
9
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a20240116definitiveproxyst.htm DEF 14A 372034
2 computer.jpg GRAPHIC 3083
3 frtx_logoxcolor.jpg GRAPHIC 64155
4 ml.jpg GRAPHIC 3585
5 proxy1a.jpg GRAPHIC 239799
6 proxy1b.jpg GRAPHIC 335398
7 proxy2a.jpg GRAPHIC 113019
8 proxy2b.jpg GRAPHIC 909065
9 tel.jpg GRAPHIC 3575
  Complete submission text file 0001628280-24-001415.txt   2670394
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21088 | Film No.: 24536811
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)